Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Trip.com, Albireo Pharma And Some Other Big Stocks Moving Higher On Thursday

Published 22/09/2022, 16:00
Updated 22/09/2022, 16:41
© Reuters.  Trip.com, Albireo Pharma And Some Other Big Stocks Moving Higher On Thursday

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording gains in today’s session.

  • Albireo Pharma, Inc. (NASDAQ: ALBO) surged 13% to $19.61. Albireo announced $115M royalty monetization agreement with Sagard.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) rose 10.7% to $41.67.
  • Amprius Technologies, Inc. (NASDAQ: AMPX) gained 10% to $10.43.
  • Virtu Financial, Inc. (NASDAQ: VIRT) rose 8.7% to $23.27 after it was reported the SEC is poised to let Wall Street keep payment-for-order-flow deals.
  • Heliogen, Inc. (NASDAQ: HLGN) gained 8.3% to $1.8850.
  • Trip.com Group Limited (NASDAQ: TCOM) gained 7.7% to $26.32 after the company reported Q2 financial results.
  • Li Auto Inc. (NASDAQ: LI) rose 7.6% to $24.84 after the company announced it will host a launch event to unveil the Li L8 on Friday, September 30, 2022, ahead of schedule.
  • Silver Crest Acquisition Corporation (NASDAQ: SLCR) gained 7.2% to $9.53.
  • Deutsche Bank (ETR:DBKGn) Aktiengesellschaft (NYSE: DB) rose 3.7% to $8.92. Deutsche Bank said its New York Branch, Deutsche Bank New York, and its affiliate Deutsche Bank Trust Company Americas have raised their prime lending from 5.50% to 6.25%.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.